肺
腺癌
医学
免疫系统
癌症研究
肿瘤科
内科学
肺腺癌
病理
癌症
免疫学
作者
Qing Bu,Liang Zhao,F Chen,F Chen,Qian Yu,Xuexin Yan,X. Chen,X. Chen,Qianyu Zhang
出处
期刊:Current Molecular Medicine
[Bentham Science]
日期:2023-06-21
卷期号:24 (6): 801-812
标识
DOI:10.2174/1566524023666230619123752
摘要
To develop optimal personalized therapy for lung adenocarcinoma (LUAD), potential biomarkers associated with the prognosis are urgently needed. It is unclear what role T Cell Leukemia Homeobox 1 (TLX1) plays in LUAD.
科研通智能强力驱动
Strongly Powered by AbleSci AI